Resistance to anthelmintic medication of equid strongyles is a worldwide phenomenon and for this reason systematic investigations of resistant parasite populations are necessary. The purpose of the present study was to investigate the presence and distribution of equid strongyles resistant to the anthelmintics used in Romania, as well as the pre-treatment and post-treatment prevalence of species of strongylid nematodes. The Faecal Egg Count Reduction Test was performed between 2010 and 2013 on a total number of 588 horses and 23 donkeys from 26 locations (subgroups). Animals of the first group (I) consisting of subgroups no. 1-11 were treated with Albendazole (ABZ), those of the second group (II) consisting of subgroups no. 12-23 with Fenbendazole (FBZ), while Ivermectin (IVM) was used on animals of the third group (III) consisting of subgroups no. 24-26. Resistant strongyles have been found in 82% (average lower limit of the 95% confidence interval, LCL95%, was 65) of the total equids from the group treated with ABZ. In the group of horses treated with FBZ, resistant strongyles were identified in 75% of the subgroups (LCL95% = 44). No resistant strongyles have been identified in IVM-treated horse groups (LCL95% = 98). The pre-treatment prevalence of the species of the Strongylinae Müller, 1780 was 22%, whereas that with nematodes of the subfamily Cyathostominae Molin, 1861 78%. Post-treatment reduction of strongyline nematodes was observed (5%), which demonstrates the sensitivity of large strongyles to common anthelmintics. The posttreatment prevalence of cyathostomes was of 95%, which proves their resistance, especially to ABZ-and FBZ-based anthelmintics.
Resistance to anthelmintic medication of horse strongyles, especially of those belonging to the subfamily Cyathostominae Molin, 1861 is a worldwide phenomenon (Kaplan 2004) . Horse strongyles resistant to benzimidazoles (BZ) and tetrahydropyrimidines (Pyrantel salt -PYR) are well known (Traversa et al. 2009, Kaplan and . The efficacy of macrocyclic lactones (ML) against horse strongyles is high (Lyons et al. 2008 ) and for the moment it is the only alternative available. Cases of cyathostomins resistant to ML have been described in both horses and donkeys (Trawford et al. 2005) . However, there is no published study on the current situation of horse strongyles resistant to the anthelmintics commonly used in Romania. According to the National Sanitary Veterinary and Food Safety Authority in Romania, there were 344 925 horses in Romania in 2011. The majority of those (98%) were bred in small individual farms in rural areas, whereas the remainder in 44 stud farms. In the period of our study, 12 drugs containing BZ, tetrahydropyrimidines, ML (Ivermectin -VM and Moxidectin -MOX) and combinations of those were registered for the treatment against horse strongyles in Romania.
According to the information provided by the veterinary practitioners, the most used anthelmintics in horses at the beginning of the 1990s were BZ-based drugs, especially Albendazole (ABZ), Mebendazole (MBZ) and Fenbendazole (FBZ), due to their efficacy and relatively low price compared to ML based drugs. This trend was maintained for over 15 years, but after this period ML-based anthelmintic drugs, especially IVM, started to be more frequently used. In contrast, there is no legal obligation to perform these treatments, nor treatment efficacy controls. Furthermore, there are also no protocols for the periodical change of the drug classes. Veterinary practitioners recommend the use of anthelmintic products in horses two to three times per year, in spring and in autumn, and possibly another dose in June-July. Some owners treat their horses by themselves, without resorting to veterinary expertise. As a result, they use doses either higher or lower than specified, or products that are recommended for other species (bovines and sheep). The lack of a national strategy regarding the compulsory prevention and control programme concerning horse nematodes may influence the structure of the strongyle species and the development of multiple anthelmintic resistance (Kaplan 2002 , Cernea et al. 2005 .
The purpose of the present study was to investigate the presence and distribution of equid strongyles resistant to the anthelmintics used in Romania, as well as the pre-and post-treatment prevalence of strongyle species.
MATERIALS AND METHODS

Study dates, locations and composition of the equid groups and subgroups
The studies were performed in the period between 2010-2013, in 26 locations in 14 counties (Fig. 1) . The total number of equids included in the study was 611 (of which 588 horses and 23 donkeys), which represent about 15% of the total equid population in the localities selected for this study (4 159 equids). The equids studied were aged between 1.5-19 years, of which 239 were males (including 19 stallions) and 372 were females.
Three groups of equids were formed depending on the locations in which the anthelmintics were used. The first group (I), consisting of subgroups 1-11 (Table 1) , included 240 horses and 23 donkeys, which were treated with ABZ 5 mg/kg (Rombendazol 10% -Romvac Company; Ecvipast N -Institute Pasteur). The second group (II), consisting of subgroups 12-23 (Table 1) , included 267 horses which were treated with FBZ 7.5 mg/kg (Vanbendazol -Vanelli SRL; Panacur -Intervet). IVM was used in the third group (III) consisting of subgroups 24-26 (Table 1) . These included 81 horses treated with doses of 0.2 mg/kg (Equirom I -Romvac Company; Equimectin -Kepro BV; Eqvamec P -Pasteur Filiala Filipeşti). Before treatment, all equids were weighted and the appropriate dose of anthelmintic was administered to them by the veterinary practitioner.
The equids included in the study belonged to private individual farms (owners), with a single subgroup (No. 26) belonging to a private stud farm. Based on anamnesis and information provided by the veterinary practitioners, previous anthelmintic treatments with ABZ, FBZ and IVM-based drugs, were administered with minimum 3 month before this study (Table 1) . Consequently, the criterion of group formation was the owner's acceptance of the protocol, as well as the actual possibility of faeces' sampling, both pre-treatment and post-treatment.
Anthelmintic resistance studies
The resistance to anthelmintic drugs was established using the Faecal Egg Count Reduction Test (FECRT) (Coles et al. 1992) . Faecal samples (200 g/sample) were collected on the same day, before drug administration, as well as 14 days post-treatment. Number of eggs per gram (EPG) was measured using the McMaster method with a 25 eggs per gram sensitivity (Herd 1992) . The arithmetic mean and prevalence of pre-treatment (Pre) and post-treatment (Post) strongyle parasitism was calculated based on EPG. The efficacy of the anthelmintic treatment was calculated based on the pre-treatment and post-treatment results obtained using FECRT, according to the following equation: 
The 95% confidence interval (CI 95%) as well as the lower confidence level (LCL) have been determined. The results obtained using FECRT have been interpreted based on the faecal egg reduction percentage, as well as on the lower limit of the 95% confidence interval (LCL 95%). In accordance with the methods recommended by the World Association for the Advancement of Veterinary Parasitology for the detection of anthelmintic resistance in horses and ruminants (Coles et al. 1992) :
resistance is present (R) if FECR < 90% and the LCL 95% < 90%; resistance is suspected (S) if FECR ≥ 90% and/or LCL 95% < 90%; no resistance (N) if FECR ≥ 90% and LCL 95% > 90%.
Species-specific identification of equid strongyles based on the morphology of third stage larvae Species-specific identification of equid strongyles and implicitly of the resistant species was determined based on the means of the larval cultures both pre-treatment and post-treatment. The cultures for larval counts have been designed using 100 g of faeces incubated for 12 days at 27 °C at an 80% relative humidity. Subsequently, the larval cultures have been baermannised for ten hours. The sediment has been collected in separate tubes, to which 100 ml of distilled water was added. After mixing, 0.1 ml of material was collected with a micropipette. The liquid phase was examined under the microscope, using a 20× objective. The number of larvae per gram (LPG) was obtained by multiplying the number of the counted larvae by a factor of ten . The strongyle species/families have been identified based on the third larval stage (L3) morphology , Kornaś et al. 2009 ). Depending on the number of larvae in each sample, between 5-100 larvae per sample were identified and the results were expressed as a percentage.
Statistical analysis
The statistical significance of the data was determined by comparing post-treatment and pre-treatment results (ANOVAunpaired t test -Welch/GraphPad InStat Inc., version 3.10). The comparison was performed for each anthelmintic drug, the measured parameter being the prevalence.
RESULTS
Anthelmintic resistance distribution
In the case of ABZ treatments (Table 2) , the reduction of the prevalence and intensity was significant in the posttreatment stage (P < 0.001). The ABZ resistance phenomenon was established in nine of the subgroups (82%) by means of the EPG quantification.
Fenbendazole treatment (Table 2 ) resulted in a significant reduction (P < 0.001) in the prevalence and intensity of strongyle parasitism, even though resistance was present in nine (75%) out of the 12 subgroups of treated horses. Resistance has been suspected in only one subgroup (No. 21) of horses (8%). FBZ was efficient against strongyles (17%) only in two horse subgroups (Nos. 12 and 13).
The results of this study have shown that the strongyles resistant to ABZ and FBZ in the studied equid groups are widespread. The ABZ-or FBZ-resistant strongyles were found in the horse subgroups that were treated once per year. ABZ-resistant strongyles have been identified in the donkey subgroup (No. 9 -Sălaj/Almaşului), even though the animals did not benefit from treatments. This fact reveals that untreated animals run a risk of contamination with resistant strongyle species and outlines the necessity of simultaneous treatments of all animals in a certain equid population. Otherwise, untreated animals may constitute a reservoir of resistant strongyles. The situation of the 23 horse subgroups (from 1-23) that were treated with ABZ and FBZ appears to be similar.
Ivermectin (Table 2) has induced an important drop (P < 0.01) of the two investigated parameters (prevalence and intensity). The strongyle populations in the horse group (III) treated with IVM-based drugs were affected in a high proportion. The reduction percentage mean of EPG was 99%, with an LCL 95% of 97-100%. Therefore, the strongyles in the IVM-treated horses have not developed resistance. The mean prevalence of strongyle infection dropped significantly 14 days after treatment (8%). The relative recent and limited use of IVM in Romania, as well as its different mechanism of action (increased the release of gamma-Aminobutyric acid (GABA) from synaptosomes of the nervous system and interference with the reproduction of nematode parasites) compared with BZ allowed this drug to remain highly efficient against strongyles and cyathostomines in the horses included in the study.
Species-specific identification of equid strongyles
A total number of 37 882 larvae were identified from 611 larval cultures in the pre-treatment stage and 17 719 larvae from the same number of larval cultures in the post-treatment stage. The mean number of larvae identi- . Cyathostomum A has 8 intestinal cells, the first two parallel (triangular or rectangular), the remaining six in a single row (trapezoidal or rectangular). Cyathostomum B has 8 intestinal cells, triangular or pentagonal shaped, arranged in double row. Cyathostomum C has 8 intestinal cells, first 4 in a double row (pentagonal, triangular or rectangular shaped), the remaining in a single row (trapezoidal) . Cyathostomum D has 8 intestinal cells, triangular or trapezoidal shaped, arranged in a single row. Cyathostomum E has 6 intestinal cells poorly defined, triangular or trapezoidal shaped, with variable display. Cyathostomum F has 7 intestinal triangular and trapezoidal elongated cells, with variable display. Cyathostomum G has 8 intestinal cells, triangular and/or rectangular (elongated and thin), trapezoidal (distal part), which set is variable. Cyathostomum H has 9 intestinal cells, triangular and elongated, the first 6 in double row and the others in a single row.
The pre-treatment prevalence of cyathostomine nematodes was 78.3% (Table 3) . We could identify G. capitatus (prevalence of 3.3%) and species of Poteriostomum (9.0%) as well as six other morphological types of third-stage larvae of cyathostomine nematodes, namely type A -51.1%, type B -0.8%, type C -10.3%, type D -3.4% and type E, F, G and H -0.5%. Six species of the subfamily Strong- ylinae were identified, with a prevalence of 22%, the most frequent being Strongylus vulgaris (10.3%) ( Table 3) . Fourteen days after the completion of the anthelmintic treatment, the species structure has altered depending on the horse group studied, on the drug used and on its efficacy (Table 3 ). In general, strongyline nematodes were much more sensitive to the drug used. The post-treatment prevalence of this subfamily was 5.4%, the reduction being highly significant in the IVM treated horse group (III), where only larvae of species of Triodontophorus were identified (0.1%). The most sensitive to all the drugs used was S. equinus, which disappeared from all of the examined samples. Strongylus vulgaris proved to be the most resistant to all ABZ-and FBZ-based drugs. The post-treatment prevalence of cyathostomine nematodes was 94.7%, representing especially ABZ-and FBZ-based anthelmintic resistant species. Small strongyles including cyathostomines proved to be the most resistant, their prevalence being 91.9%, of which type A represented 77.3%, type B -2.8%, type C -6.8%, type D -4.3% and types E-H 0.7%. In the IVM treated horse group (III), we could identify only a small number of G. capitatus (0.8%) and species of Poteriostomum (2.0%) as well as third-stage larvae of type A (83.3%) and C (8.6%).
In general, the post-treatment decrease of the prevalence was statistically significant (Table 3) in the species of the Strongylinae, which shows good efficacy of the treatment with ABZ, FBZ and especially with IVM. Nevertheless, there was a significant increase in the prevalence of the infestation with cyathostomine nematodes, which demonstrates the resistance of these species to ABZ and FBZ.
DISCUSSION
The studies conducted all over the world in the past 23 years have revealed an increase of the prevalence of cyathostomine nematodes as well as a decrease of the prevalence of large strongyles (Kaplan 2002 , Kuzmina and Kharchenko 2008 , Traversa et al. 2012 .
Regardless of the BZ resistance quantification method employed, the values obtained in this study are close to those found in other European countries, where the prevalence of resistant strongyles, especially that of cyathostomins, is over 70% (Wirtherle et al. 2004 , Traversa et al. 2007 . In the absence of previous data on the situation in Romania and based on the data available in the literature (Kaplan 2002) , we can assume that resistance of strongyles to BZs occurred due to their prolonged and exclusive use, and sometimes even to their irrational use, beyond the limits and conditions stipulated by the producer (overdosage/ underdosage) (Conder and Campbell 1995) .
Despite the fact that between 2005-2009, the use of BZs in horses was significantly reduced, being reinstated only in the last three or four years, the resistant strongyle species have not disappeared, a phenomenon that has been mentioned in other studies as well (Osterman Lind et al. 2007 , Lyons et al. 2007 ). It has not yet been demonstrated that it is possible to re-establish the efficacy of a drug category to which a certain level of resistance had previously existed, even if these drugs were not used for a given period of time (Slocombe et al. 2008 , von Samson-Himmelstjerna 2012 .
However, in terms of anthelmintic resistance, the control of this phenomenon must be based on, and adapted to, the specificity of each individual horse group. This would Craterostomum acuticaudatum 1.7 ± 1.6 0.8 ± 1.2 2.3 ± 1.4 1.2 ± 1.5 0.8 ± 0.8 0 1.6 0.7 P 0.1748 0.0733 Oesophagodontus robustus 3.5 ± 1.6 0.5 ± 0.9 6.0 ± 2.9 1.7 ± 2.1 5.7 ± 3.2 0 5.0 0.7 P <0.0001 0.0004 Strongylus edentatus 2.2 ± 1.9 0.5 ± 0.9 2.7 ± 1.8 0.5 ± 0. 12.6 ± 3.5 2.4 ± 2.5 11.2 ± 3.2 4.3 ± 4.3 7.1 ± 1.1 0 10.3 2.2 P <0.0001 0.0002 Triodontophorus species 2.9 ± 2.2 1.2 ± 1.6 2.5 ± 1.5 2.8 ± 2.9 2.1 ± 1.6 0.1 ± 0.12 2.5 1.3 P 0.0423 0.7282 0.0938 Cyathostominae 78.3 94.7 Cyathostomine nematodes subtypes A-H 65.6 ± 6.6 89.9 ± 6.0 62.9 ± 6.1 86.1 ± 8.3 69.4 ± 6.4 99.7 ± 0.42 66.0 91.9 P <00001 <0.0001 0.0012 Gyalocephalus capitatus 2.5 ± 2.9 0.9 ± 1.0 4.6 ± 4.5 1.1 ± 1.9 2.7 ± 1.6 0.3 ± 0.46 3.3 0.8 P 0.0819 0.0227 0.0633 Poteriostomum spp.
8.7 ± 3.7 3.7 ± 4.2 7.6 ± 3.5 2.2 ± 1.9 10.8 ± 5.5 0 9.0 2.0 P 0.0072 <0.0001 depend on the drug molecule and frequency of the treatments, the selection of the anthelmintic drug based on the results of the efficacy tests, the age of the animals, pasture hygiene and management (Francisco et al. 2012 , von Samson-Himmelstjerna 2012 . The study completed in Romania on the 26 equid subgroups reveals the possibility that this phenomenon could be the result of the anthelmintic drugs administered, to which nematodes of the subfamily Strongylinae are much more sensitive (especially to IVM) than members of the Cyathostominae. The current situation in Romania is due, to a large extent, to the lack of a clear and sustained nematode control programme in equids. Moreover, the clinical symptoms in massive infections with cyathostomines are neither obvious nor specific (Love et al. 1999 ) and thus the horse owners do not request anthelmintic treatments. In order to monitor the present situation of strongyles resistant to the anthelmintic drugs currently and commonly used in Romania, a nation-wide programme should be implemented. This should include: (i) periodic epidemiological studies to accurately establish their intensity and prevalence; (ii) the onset of prophylactic and specific treatments, according to FECRT test results; (iii) therapeutic programmes correlated with the identified species; (iv) treatment of the entire group of horses, wherever resistant strongyles are identified; (v) education of horse owners; (vi) vet prescription based acquisition of the anthelmintics (Nielsen et al. 2006) ; and (vii) pasture hygiene and management skills optimisation in order to reduce the rate of re-infection (Nielsen 2012) .
